387 related articles for article (PubMed ID: 33329389)
1. Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor.
Luo P; Zhang L; Yang L; An Z; Tan H
Front Endocrinol (Lausanne); 2020; 11():580264. PubMed ID: 33329389
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics, Diagnosis, and Treatment of Thyroid Stimulating Hormone-Secreting Pituitary Neuroendocrine Tumor (TSH PitNET): A Single-Center Experience.
Heo J; Suh YL; Kim SH; Kong DS; Nam DH; Lee WJ; Kim ST; Hong SD; Ryu S; Lee YB; Kim G; Jin SM; Kim JH; Hur KY
Endocrinol Metab (Seoul); 2024 Apr; 39(2):387-396. PubMed ID: 38311828
[TBL] [Abstract][Full Text] [Related]
3. The molecular biology of thyrotroph pituitary neuroendocrine tumors.
Horiguchi K
Endocr J; 2023 Feb; 70(2):135-139. PubMed ID: 36653153
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-secreting tumor "TSH-PitNET": From diagnosis to treatment.
Briet C; Suteau V; Illouz F; Rodien P
Ann Endocrinol (Paris); 2023 Aug; 84(4):407-412. PubMed ID: 36716819
[TBL] [Abstract][Full Text] [Related]
5. Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review.
Peng G; Guo C; Lv Y; Li D; Zhou L; Shen R; Chen Y; Zheng X; Sun Z; Zheng H; Long M
BMC Endocr Disord; 2022 Dec; 22(1):325. PubMed ID: 36539773
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.
Sanno N; Teramoto A; Osamura RY
J Neurooncol; 2001 Sep; 54(2):179-86. PubMed ID: 11761434
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Case reports and follow-up of nine patients.
Gesundheit N; Petrick PA; Nissim M; Dahlberg PA; Doppman JL; Emerson CH; Braverman LE; Oldfield EH; Weintraub BD
Ann Intern Med; 1989 Nov; 111(10):827-35. PubMed ID: 2479309
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy.
Zhou Y; Zhang A; Fang C; Yuan L; Shao A; Xu Y; Zhou D
CNS Neurosci Ther; 2023 Oct; 29(10):2744-2759. PubMed ID: 37341156
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.
Jimenez-Canizales CE; Rojas W; Alonso D; Romero I; Tabares S; Veronesi Zuluaga LA; Modica R; Colao A
J Endocrinol Invest; 2023 Nov; 46(11):2275-2286. PubMed ID: 37002436
[TBL] [Abstract][Full Text] [Related]
10. Multilineage Pituitary Neuroendocrine Tumors (PitNETs) Expressing PIT1 and SF1.
Asa SL; Mete O; Riddle ND; Perry A
Endocr Pathol; 2023 Sep; 34(3):273-278. PubMed ID: 37268858
[TBL] [Abstract][Full Text] [Related]
11. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients.
Wynne AG; Gharib H; Scheithauer BW; Davis DH; Freeman SL; Horvath E
Am J Med; 1992 Jan; 92(1):15-24. PubMed ID: 1346235
[TBL] [Abstract][Full Text] [Related]
12. The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Grieve J; Dorward N; Mendoza N; Nair R; Muquit S; Grossman AB; Korbonits M
J Neuroendocrinol; 2021 Dec; 33(12):e13052. PubMed ID: 34708902
[TBL] [Abstract][Full Text] [Related]
13. Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.
Marques P; Barry S; Carlsen E; Collier D; Ronaldson A; Awad S; Dorward N; Grieve J; Mendoza N; Muquit S; Grossman AB; Balkwill F; Korbonits M
Acta Neuropathol Commun; 2019 Nov; 7(1):172. PubMed ID: 31703742
[TBL] [Abstract][Full Text] [Related]
14. Case Report and Literature Review: Ectopic Thyrotropin-Secreting Pituitary Adenoma in the Suprasellar Region.
Li X; Zhao B; Hou B; Wang J; Zhu J; Yao Y; Lian X
Front Endocrinol (Lausanne); 2021; 12():619161. PubMed ID: 33776916
[TBL] [Abstract][Full Text] [Related]
15. Ectopic pituitary adenoma of the TSH-secreting sphenoidal sinus with excellent response to somatostatin analogs. Theory of the embryogenesis and literature review from a clinical case.
Ortiz E; Peldoza M; Monnier E; Gejman R; Henriquez M; Barra MI; Gayoso R; Sapunar J; Villaseca M; Guzmán P
Steroids; 2020 Feb; 154():108535. PubMed ID: 31704334
[TBL] [Abstract][Full Text] [Related]
16. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
[TBL] [Abstract][Full Text] [Related]
17. Differential expression levels of β-catenin are associated with invasive behavior of both functional and non-functional pituitary neuroendocrine tumor (PitNET).
Taghavi SF; Ghorbani M; Panahi M; Nazem S; Karimi M; Salimi V; Tavakoli-Yaraki M
Mol Biol Rep; 2023 Aug; 50(8):6425-6434. PubMed ID: 37326745
[TBL] [Abstract][Full Text] [Related]
18. Secondary Hyperthyroidism due to an Ectopic Thyrotropin-Secreting Neuroendocrine Pituitary Tumor: A Case Report.
Trummer C; Reiher H; Theiler-Schwetz V; Pandis M; Gstettner C; Potzinger P; Keck T; Pieber TR; Lax S; Haybaeck J; Stepan V; Pilz S
Eur Thyroid J; 2020 Feb; 9(2):106-112. PubMed ID: 32257960
[TBL] [Abstract][Full Text] [Related]
19. Temozolomide cytoreductive treatment in a giant cabergoline-resistant prolactin-secreting pituitary neuroendocrine tumor.
Ceccato F; Lombardi G; Albiger N; Mazzai L; Pambuku A; Rolma G; Zagonel V; Scaroni C
Anticancer Drugs; 2019 Jun; 30(5):533-536. PubMed ID: 30986806
[TBL] [Abstract][Full Text] [Related]
20. Lysine Methyltransferase 5A Promotes the Progression of Growth Hormone Pituitary Neuroendocrine Tumors through the Wnt/β-Catenin Signaling Pathway.
Li J; Song H; Chen T; Zhang S; Zhang C; Ma C; Zhang L; Wang T; Qian Y; Deng X
Neuroendocrinology; 2024; 114(6):589-601. PubMed ID: 38565081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
